194 related articles for article (PubMed ID: 17300357)
1. Efficacy of eletriptan in triptan-naïve patients: results of a combined analysis.
Martin VT; Valade D; Almas M; Hettiarachchi J; Sikes C; Albert KS; Parsons B
Headache; 2007 Feb; 47(2):181-8. PubMed ID: 17300357
[TBL] [Abstract][Full Text] [Related]
2. Eletriptan for the acute treatment of migraine in adolescents: results of a double-blind, placebo-controlled trial.
Winner P; Linder SL; Lipton RB; Almas M; Parsons B; Pitman V
Headache; 2007 Apr; 47(4):511-8. PubMed ID: 17445100
[TBL] [Abstract][Full Text] [Related]
3. Predictors of migraine headache recurrence: a pooled analysis from the eletriptan database.
Dodick DW; Lipton RB; Goadsby PJ; Tfelt-Hansen P; Ferrari MD; Diener HC; Almas M; Albert KS; Parsons B
Headache; 2008 Feb; 48(2):184-93. PubMed ID: 18234045
[TBL] [Abstract][Full Text] [Related]
4. Early intervention with almotriptan: results of the AEGIS trial (AXERT Early Migraine Intervention Study).
Mathew NT; Finlayson G; Smith TR; Cady RK; Adelman J; Mao L; Wright P; Greenberg SJ;
Headache; 2007 Feb; 47(2):189-98. PubMed ID: 17300358
[TBL] [Abstract][Full Text] [Related]
5. Fixed-dose sumatriptan and naproxen in poor responders to triptans with a short half-life.
Mathew NT; Landy S; Stark S; Tietjen GE; Derosier FJ; White J; Lener SE; Bukenya D
Headache; 2009 Jul; 49(7):971-82. PubMed ID: 19486178
[TBL] [Abstract][Full Text] [Related]
6. Efficacy of eletriptan in migraine-related functional impairment: functional and work productivity outcomes.
Silberstein SD; Cady RK; Sheftell FD; Almas M; Parsons B; Albert KS
Headache; 2007 May; 47(5):673-82. PubMed ID: 17501848
[TBL] [Abstract][Full Text] [Related]
7. Sumatriptan nasal spray in adolescent migraineurs: a randomized, double-blind, placebo-controlled, acute study.
Winner P; Rothner AD; Wooten JD; Webster C; Ames M
Headache; 2006 Feb; 46(2):212-22. PubMed ID: 16492230
[TBL] [Abstract][Full Text] [Related]
8. Effect of pain intensity and time to administration on responsiveness to almotriptan: results from AXERT 12.5 mg Time Versus Intensity Migraine Study (AIMS).
Freitag FG; Finlayson G; Rapoport AM; Elkind AH; Diamond ML; Unger JR; Fisher AC; Armstrong RB; Hulihan JF; Greenberg SJ;
Headache; 2007 Apr; 47(4):519-30. PubMed ID: 17445101
[TBL] [Abstract][Full Text] [Related]
9. Identification of negative predictors of pain-free response to triptans: analysis of the eletriptan database.
Diener HC; Dodick DW; Goadsby PJ; Lipton RB; Almas M; Parsons B
Cephalalgia; 2008 Jan; 28(1):35-40. PubMed ID: 17941878
[TBL] [Abstract][Full Text] [Related]
10. Meta-analysis of the efficacy and safety of zolmitriptan in the acute treatment of migraine.
Chen LC; Ashcroft DM
Headache; 2008 Feb; 48(2):236-47. PubMed ID: 18179569
[TBL] [Abstract][Full Text] [Related]
11. Comparing the efficacy of eletriptan for migraine in women during menstrual and non-menstrual time periods: a pooled analysis of randomized controlled trials.
Bhambri R; Martin VT; Abdulsattar Y; Silberstein S; Almas M; Chatterjee A; Ramos E
Headache; 2014 Feb; 54(2):343-54. PubMed ID: 24256184
[TBL] [Abstract][Full Text] [Related]
12. [Spanish contribution to the clinical development of eletriptan: an analysis of controlled studies].
Pascual J; Leira R; Lainez JM; Liaño H; Díez-Tejedor E; Navarro A; Jiménez D; Ezpeleta D; Mateos V; Madrigal M; Palacios G;
Neurologia; 2004 Oct; 19(8):414-9. PubMed ID: 15470580
[TBL] [Abstract][Full Text] [Related]
13. Almotriptan in migraine patients who respond poorly to oral sumatriptan: a double-blind, randomized trial.
Diener HC; Gendolla A; Gebert I; Beneke M
Headache; 2005; 45(7):874-82. PubMed ID: 15985104
[TBL] [Abstract][Full Text] [Related]
14. Eletriptan in migraine patients reporting unsatisfactory response to rizatriptan.
Goldstein J; Tiseo PT; Albert KS; Li C; Sikes CR
Headache; 2006; 46(7):1142-50. PubMed ID: 16866718
[TBL] [Abstract][Full Text] [Related]
15. Eletriptan for the acute treatment of migraine: results of bridging a Japanese study to Western clinical trials.
Sakai F; Diener HC; Ryan R; Poole P
Curr Med Res Opin; 2004 Mar; 20(3):269-77. PubMed ID: 15025836
[TBL] [Abstract][Full Text] [Related]
16. Outcome for headache and pain-free nonresponders to treatment of the first attack: a pooled post-hoc analysis of four randomized trials of eletriptan 40 mg.
Landy SH; Tepper SJ; Schweizer E; Almas M; Ramos E
Cephalalgia; 2014 Apr; 34(5):376-81. PubMed ID: 24265285
[TBL] [Abstract][Full Text] [Related]
17. Early intervention in migraine with sumatriptan tablets 50 mg versus 100 mg: a pooled analysis of data from six clinical trials.
Winner P; Landy S; Richardson M; Ames M
Clin Ther; 2005 Nov; 27(11):1785-94. PubMed ID: 16368449
[TBL] [Abstract][Full Text] [Related]
18. Zolmitriptan 5 mg nasal spray: efficacy and onset of action in the acute treatment of migraine--results from phase 1 of the REALIZE Study.
Gawel M; Aschoff J; May A; Charlesworth BR;
Headache; 2005 Jan; 45(1):7-16. PubMed ID: 15663607
[TBL] [Abstract][Full Text] [Related]
19. Treatment of sinus headache as migraine: the diagnostic utility of triptans.
Kari E; DelGaudio JM
Laryngoscope; 2008 Dec; 118(12):2235-9. PubMed ID: 18948830
[TBL] [Abstract][Full Text] [Related]
20. Eletriptan in the early treatment of acute migraine: influence of pain intensity and time of dosing.
Brandes JL; Kudrow D; Cady R; Tiseo PJ; Sun W; Sikes CR
Cephalalgia; 2005 Sep; 25(9):735-42. PubMed ID: 16109056
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
